Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Yoshiya Ueyama"'
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Programmed death-1 ligand-1 (PD-L1) an important cancer biomarker that can suppress the immune system and its high expression is often reported to be related with increased tumor aggressiveness in some cancers. Here, we examined a
Externí odkaz:
https://doaj.org/article/2199afc61ef140ddb2d43931a5880832
Publikováno v:
Japanese Dental Science Review, Vol 53, Iss 3, Pp 61-77 (2017)
Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer tr
Externí odkaz:
https://doaj.org/article/b576f081fd3a4d0c943cfb5f3e7f71de
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Mucositis and dermatitis induced by anticancer agents are common complications of anticancer therapies. In this study, we evaluated the efficacy of Elental (Ajinomoto Pharmaceutical Ltd, Tokyo, Japan), an elemental diet with glutamine in the treatmen
Externí odkaz:
https://doaj.org/article/e724535cc059473aafaa3ad49f50d74c
Autor:
Kazuya Inoue, Hiroyuki Nakano, Hokuto Suga, Chikara Yoshimura, Tomonori Iwasaki, Yoshiya Ueyama, Katsuaki Mishima, Naoko Imagawa, Takamitsu Mano, Takaaki Ueno, Kei Suzuki, Yoshihide Mori
Publikováno v:
Journal of Hard Tissue Biology. 29:49-52
Mandibular micrognathia is one of the characteristics of obstructive sleep apnea syndrome. The purpose of this study was to assess the effects of bimaxillary surgery without maxillary advancement on the upper airway using computational fluid dynamics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6576999fdadc372bf6f4118bc7094a55
https://doi.org/10.2485/jhtb.29.49
https://doi.org/10.2485/jhtb.29.49
Autor:
Yasutaka Itashiki, Takanori Takenawa, Tarannum Ferdous, Koji Harada, Katsuaki Mishima, Yoshiya Ueyama
Publikováno v:
Oncology Letters
Vascular endothelial growth factor (VEGF) serves an important role in new blood vessel formation or angiogenesis, which is a critical event in tumor growth and metastasis. Bevacizumab is a humanized monoclonal antibody against VEGF-A, whereas S-1 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa3bf7ab418d50b19038f59a9096baa
https://pubmed.ncbi.nlm.nih.gov/34429770
https://pubmed.ncbi.nlm.nih.gov/34429770
Autor:
Kenichiro Uchida, Hirotsugu Umeda, Katsuaki Mishima, Daiju Horinaga, Koji Harada, Yoshiya Ueyama, Takamitsu Mano, Masaki Okafuji
Publikováno v:
Yamaguchi Medical Journal. 66:211-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::036a47779363d7814acf17e135b89505
https://doi.org/10.2342/ymj.66.211
https://doi.org/10.2342/ymj.66.211
Publikováno v:
Oncology Letters. 14:3349-3356
Gimeracil or 5-chloro-2,4-dihydroxypyridine (CDHP) enhances the antitumor effects of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase (DPD), which is involved in the degradation of 5-FU. CDHP, as part of a combination therapy, was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e8102a5e5fe529f76541ed889027e69
https://doi.org/10.3892/ol.2017.6602
https://doi.org/10.3892/ol.2017.6602
Publikováno v:
Integrative Cancer Therapies
Integrative Cancer Therapies, Vol 17 (2018)
Integrative Cancer Therapies, Vol 17 (2018)
Mucositis and dermatitis induced by anticancer agents are common complications of anticancer therapies. In this study, we evaluated the efficacy of Elental (Ajinomoto Pharmaceutical Ltd, Tokyo, Japan), an elemental diet with glutamine in the treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f575cf48af2661112907db679f37205c
http://europepmc.org/articles/PMC6041898
http://europepmc.org/articles/PMC6041898
Autor:
Jutaro Miyamoto, Takanori Takenawa, Nagahiro Tsuboi, Yoshiya Ueyama, Kenichiro Uchida, Takahiro Fujii
Publikováno v:
Japanese Journal of Oral and Maxillofacial Surgery. 63:645-652
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61d62ae3a308ff533e32955e66870c59
https://doi.org/10.5794/jjoms.63.645
https://doi.org/10.5794/jjoms.63.645
Publikováno v:
Journal of Japanese Society of Oral Oncology. 29:135-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a07928002af41b5aae6d57773c003350
https://doi.org/10.5843/jsot.29.135
https://doi.org/10.5843/jsot.29.135